Central amylin acts as an adiposity signal to control body weight and energy expenditure
about
The brain and brown fatAmylin at the interface between metabolic and neurodegenerative disordersGut hormones such as amylin and GLP-1 in the control of eating and energy expenditure.Associations of amylin with inflammatory markers and metabolic syndrome in apparently healthy Chinese.Neuronal receptor activity-modifying protein 1 promotes energy expenditure in mice.Ovariectomy and overeating palatable, energy-dense food increase subcutaneous adipose tissue more than intra-abdominal adipose tissue in rats.Ablation of the transcriptional regulator Id1 enhances energy expenditure, increases insulin sensitivity, and protects against age and diet induced insulin resistance, and hepatosteatosis.Genetic Similarities between Compulsive Overeating and Addiction Phenotypes: A Case for "Food Addiction"?Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.Islet Amyloid Polypeptide: Structure, Function, and Pathophysiology.Human islet amyloid polypeptide at the air-aqueous interface: a Langmuir monolayer approach.Endogenous VMH amylin signaling is required for full leptin signaling and protection from diet-induced obesity.Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypassIslet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.The interaction of amylin with other hormones in the control of eating.Role of Amylin in Type 1 and Type 2 Diabetes.Amylin-mediated control of glycemia, energy balance, and cognition.A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference.The dual amylin- and calcitonin-receptor agonist KBP-042 increases insulin sensitivity and induces weight loss in rats with obesity.KBP-088, a novel DACRA with prolonged receptor activation, is superior to davalintide in terms of efficacy on body weight.The Receptor for Advanced Glycation Endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and Exploiting Common Ground for Novel Amyloidosis Therapies.
P2860
Q26865368-ABE5E870-895E-4705-A894-2657A64EAD5CQ27003342-ED7F6F8F-93A1-4484-ABB0-8D1F357F288FQ33838133-14023B2B-43FC-497D-AE77-BEB94D770A7DQ34026295-77475C44-BEFC-4833-8366-66EDEF7F8894Q34718618-E234F117-0AE8-4E89-B74C-D14438B4B47EQ35044345-86E02C4B-27B8-43E5-AE6E-A1A6030AFBDDQ35647980-67E58794-4324-4B97-854B-8B4A5709B914Q35811863-3BFBBFA8-8810-4D8E-A94D-D12510B33391Q36153252-B4931EFE-7CCC-4EB5-9C81-50D5396568D2Q36327915-DE0E7012-131B-4D08-A561-DAC1E8221D5BQ36344010-D858393A-37AF-4253-8E73-11E875CE939CQ36904734-645DD5ED-7539-4E70-A4E0-E54B52AAF131Q37100802-5388F319-01F8-4987-A3D1-7798064D1475Q37120813-BB6EC1AC-9BD2-46CB-8883-9FBE5D7C17C2Q38031993-8AC4C75D-9D7E-4BF2-BD00-5C8E004A8CD5Q38596374-FB5E4276-78AE-40AC-BB29-201E2B20267EQ38753342-C72B287C-3C4A-4220-829C-5A63F7804EC9Q39008520-BC9560B7-912E-4753-9627-BC4154C36A55Q47296897-C56E9ACD-131E-453E-8D7B-0724024C7458Q47323414-756AFE81-94E9-4D53-A0B5-9182B8B9CAADQ52583445-BDEDABCD-861E-4BBD-B7C0-CE4ECA0B0879
P2860
Central amylin acts as an adiposity signal to control body weight and energy expenditure
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@ast
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@en
type
label
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@ast
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@en
prefLabel
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@ast
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@en
P2093
P2860
P1476
Central amylin acts as an adiposity signal to control body weight and energy expenditure
@en
P2093
Christian Löwenstein
Manuela Munz
Peter Y Wielinga
Sabine Muff
Stephen C Woods
P2860
P356
10.1016/J.PHYSBEH.2010.04.012
P407
P577
2010-04-21T00:00:00Z